Naz Rahman's Stock Ratings

Maxim Group Analyst

Naz Rahman is an analyst at Maxim Group. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/28/2024

Overall Average Return

-24.6%

Smart Score

33.1%

Overall Average Return Percentile

10th

Number of Ratings

36
Buy NowGet Alert
06/26/2024PRFXBuy Now
PainReform
$0.51292.62%$2 → $2ReiteratesBuy → BuyGet Alert
06/25/2024ALIMBuy Now
Alimera Sciences
$5.55DowngradeBuy → HoldGet Alert
06/04/2024VKTXBuy Now
Viking Therapeutics
$53.10125.99%$120 → $120ReiteratesBuy → BuyGet Alert
05/22/2024VRPXBuy Now
Virpax Pharmaceuticals
$0.52DowngradeBuy → HoldGet Alert
05/01/2024PALIBuy Now
Palisade Bio
$4.50400% → $22.5ReiteratesBuy → BuyGet Alert
04/16/2024PALIBuy Now
Palisade Bio
$4.50400%$22.5 → $22.5MaintainsBuyGet Alert
03/25/2024ALIMBuy Now
Alimera Sciences
$5.5580.2% → $10Initiates → BuyGet Alert
03/18/2024AGRXBuy Now
Agile Therapeutics
$1.41DowngradeBuy → HoldGet Alert
03/15/2024VKTXBuy Now
Viking Therapeutics
$53.10125.99% → $120ReiteratesBuy → BuyGet Alert
03/15/2024QNRXBuy Now
Quoin Pharmaceuticals
$0.58583.76%$15 → $4MaintainsBuyGet Alert
02/08/2024VKTXBuy Now
Viking Therapeutics
$53.10-5.84%$35 → $50MaintainsBuyGet Alert
01/31/2024VRTXBuy Now
Vertex Pharmaceuticals
$469.00DowngradeBuy → HoldGet Alert
12/19/2023CINGBuy Now
Cingulate
$0.35DowngradeBuy → HoldGet Alert
12/18/2023CINGBuy Now
Cingulate
$0.35DowngradeBuy → HoldGet Alert
12/08/2023PTPIBuy Now
Petros Pharma
$0.46773.36% → $4Initiates → BuyGet Alert
11/17/2023PCSABuy Now
Processa Pharma
$2.00DowngradeBuy → HoldGet Alert
11/17/2023PALIBuy Now
Palisade Bio
$4.50-66.67% → $22.5UpgradeHold → BuyGet Alert
09/22/2023AGRXBuy Now
Agile Therapeutics
$1.41253.61% → $5UpgradeHold → BuyGet Alert
08/09/2023AYTUBuy Now
Aytu BioPharma
$2.9171.92% → $5Initiates → BuyGet Alert
05/11/2023SCPHBuy Now
scPharmaceuticals
$4.35359.77%$13 → $20MaintainsBuyGet Alert
03/30/2023PALIBuy Now
Palisade Bio
$4.501011.11% → $750UpgradeHold → BuyGet Alert
01/12/2023PCSABuy Now
Processa Pharma
$2.00150%$180 → $100MaintainsBuyGet Alert
12/20/2022VKTXBuy Now
Viking Therapeutics
$53.10-71.75%$10 → $15MaintainsBuyGet Alert
11/22/2022CINGBuy Now
Cingulate
$0.35758.86% → $60Initiates → BuyGet Alert
08/22/2022CRXTBuy Now
Clarus Therapeutics Hldgs
DowngradeBuy → HoldGet Alert
08/19/2022PALIBuy Now
Palisade Bio
$4.50DowngradeBuy → HoldGet Alert
08/02/2022SCPHBuy Now
scPharmaceuticals
$4.35Initiates → BuyGet Alert
07/26/2022AGRXBuy Now
Agile Therapeutics
$1.41-29.28% → $50UpgradeHold → BuyGet Alert
06/09/2022VRPXBuy Now
Virpax Pharmaceuticals
$0.52673.25% → $40Initiates → BuyGet Alert
05/09/2022ATNFBuy Now
180 Life Sciences
$1.55DowngradeBuy → HoldGet Alert
04/19/2022PCSABuy Now
Processa Pharma
$2.00350% → $180Initiates → BuyGet Alert
02/25/2022NXGLBuy Now
NexGel
$2.29162.01% → $6Initiates → BuyGet Alert
01/07/2022QNRXBuy Now
Quoin Pharmaceuticals
$0.58754.7% → $750Initiates → BuyGet Alert
01/07/2022NRSNBuy Now
NeuroSense Therapeutics
$1.11530.63% → $7Initiates → BuyGet Alert
12/07/2021FWBIBuy Now
First Wave BioPharma
DowngradeBuy → HoldGet Alert
08/31/2021PALIBuy Now
Palisade Bio
$4.5055.56% → $5250Initiates → BuyGet Alert

Recent Analyst Stock Rating News

The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free